Trending Topic

3 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

It is with pride and gratitude that we reflect on the remarkable 10-year journey of European Journal of Arrhythmia & Electrophysiology. With the vital contributions of all of our esteemed authors, reviewers and editorial board members, the journal has served as a platform for groundbreaking research, clinical insights and news that have helped shape the […]

Stavros Stavrakis, HRS 2019 – the TREAT AF Trial

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jun 13th 2019

Dr Stavros Stavrakis (Associate Professor of Medicine, University of Oklahoma Health Sciences Center, Oklahoma, OK, USA) about the current unmet needs in paroxysmal atrial fibrillation and the Transcutaneous Electrical Vagus Nerve Stimulation to Suppress Atrial Fibrillation (TREAT AF) trial.

Speaker’s Disclosures: Stavros Stavrakis has nothing to disclose in relation to this video interview.

Questions:
1. What are the current unmet needs in paroxysmal atrial fibrillation? (0:06)
2. What are you hoping to demonstrate from the Transcutaneous Electrical Vagus Nerve Stimulation to Suppress Atrial Fibrillation (TREAT AF) trial? (0:42)
3. What are the potential clinical benefits from these results? (1:17)
4. What are your highlights from Heart Rhythm 2019? (1:58)

touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup